FDA: More High Blood Pressure Drugs Recalled Over Cancer-Linked Ingredient

A pharmacy technician grabs a bottle of drugs off a shelve at the central pharmacy of Intermountain Heathcare on September 10, 2018 in Midvale, Utah. Photo by George Frey/Getty Images

The U.S. Food and Drug Administration (FDA) announced it is expanding the recall of medication used to treat high blood pressure.

The agency, in a statement on Sept. 19, said Torrent Pharmaceuticals Limited is recalling several batches of Losartan Potassium tablets after “trace amounts” of N-Methylnitrosobutyric acid, or NMDA, were discovered in the medication. NMDA has been linked to cancer.